title: Response to Nandakoban et al. Acute tubulointerstitial nephritis following treatment with exenatide.
authors.forename: D O
authors.initials: DO
authors.lastname: Rees
authors.forename: D E
authors.initials: DE
authors.lastname: Price
authors.forename: S C
authors.initials: SC
authors.lastname: Bain
authors.forename: J W
authors.initials: JW
authors.lastname: Stephens
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D009395:Nephritis, Interstitial / Q000139:chemically induced*; D010455:Peptides / Q000009:adverse effects*; D014688:Venoms / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms